Advanced Science (May 2020)
Germline Polymorphisms and Length of Survival of Nasopharyngeal Carcinoma: An Exome‐Wide Association Study in Multiple Cohorts
- Yun‐Miao Guo,
- Jie‐Rong Chen,
- Yan‐Chun Feng,
- Melvin L. K. Chua,
- Yanni Zeng,
- Edwin Pun Hui,
- Allen K. C. Chan,
- Lin‐Quan Tang,
- Lin Wang,
- Qian Cui,
- Hui‐Qiong Han,
- Chun‐Ling Luo,
- Guo‐Wang Lin,
- Yan Liang,
- Yang Liu,
- Zhong‐Lian He,
- Yu‐Xiang Liu,
- Pan‐Pan Wei,
- Chu‐Jun Liu,
- Wan Peng,
- Bo‐Wei Han,
- Xiao‐Yu Zuo,
- Enya H. W. Ong,
- Eugenia L. L. Yeo,
- Kar Perng Low,
- Gek San Tan,
- Tony K. H. Lim,
- Jacqueline S. G. Hwang,
- Bo Li,
- Qi‐Sheng Feng,
- Xiaojun Xia,
- Yun‐Fei Xia,
- Josephine Ko,
- Wei Dai,
- Maria L. Lung,
- Anthony T. C. Chan,
- Dennis Y. M. Lo,
- Mu‐Sheng Zeng,
- Hai‐Qiang Mai,
- Jianjun Liu,
- Yi‐Xin Zeng,
- Jin‐Xin Bei
Affiliations
- Yun‐Miao Guo
- Sun Yat‐sen University Cancer Center State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy Guangzhou 510060 P. R. China
- Jie‐Rong Chen
- Sun Yat‐sen University Cancer Center State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy Guangzhou 510060 P. R. China
- Yan‐Chun Feng
- Sun Yat‐sen University Cancer Center State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy Guangzhou 510060 P. R. China
- Melvin L. K. Chua
- Division of Radiation Oncology and Division of Medical Sciences National Cancer Centre Singapore Singapore 169610 Singapore
- Yanni Zeng
- Sun Yat‐sen University Cancer Center State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy Guangzhou 510060 P. R. China
- Edwin Pun Hui
- Department of Clinical Oncology State Key Laboratory of Translational Oncology Prince of Wales Hospital The Chinese University of Hong Kong Shatin, New Territories Hong Kong SAR P. R. China
- Allen K. C. Chan
- Department of Chemical Pathology Li Ka Shing Institute of Health Sciences State Key Laboratory of Translational Oncology The Chinese University of Hong Kong Shatin, New Territories Hong Kong SAR P. R. China
- Lin‐Quan Tang
- Sun Yat‐sen University Cancer Center State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy Guangzhou 510060 P. R. China
- Lin Wang
- Sun Yat‐sen University Cancer Center State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy Guangzhou 510060 P. R. China
- Qian Cui
- Guangdong Provincial People's Hospital Guangdong Academy of Medical Sciences Guangzhou 510080 P. R. China
- Hui‐Qiong Han
- Department of Oncology The First Affiliated Hospital of Zhengzhou University Zhengzhou 450052 P. R. China
- Chun‐Ling Luo
- Sun Yat‐sen University Cancer Center State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy Guangzhou 510060 P. R. China
- Guo‐Wang Lin
- Sun Yat‐sen University Cancer Center State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy Guangzhou 510060 P. R. China
- Yan Liang
- Sun Yat‐sen University Cancer Center State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy Guangzhou 510060 P. R. China
- Yang Liu
- Sun Yat‐sen University Cancer Center State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy Guangzhou 510060 P. R. China
- Zhong‐Lian He
- Sun Yat‐sen University Cancer Center State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy Guangzhou 510060 P. R. China
- Yu‐Xiang Liu
- Sun Yat‐sen University Cancer Center State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy Guangzhou 510060 P. R. China
- Pan‐Pan Wei
- Sun Yat‐sen University Cancer Center State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy Guangzhou 510060 P. R. China
- Chu‐Jun Liu
- Sun Yat‐sen University Cancer Center State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy Guangzhou 510060 P. R. China
- Wan Peng
- Sun Yat‐sen University Cancer Center State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy Guangzhou 510060 P. R. China
- Bo‐Wei Han
- Sun Yat‐sen University Cancer Center State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy Guangzhou 510060 P. R. China
- Xiao‐Yu Zuo
- Sun Yat‐sen University Cancer Center State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy Guangzhou 510060 P. R. China
- Enya H. W. Ong
- Division of Radiation Oncology and Division of Medical Sciences National Cancer Centre Singapore Singapore 169610 Singapore
- Eugenia L. L. Yeo
- Division of Radiation Oncology and Division of Medical Sciences National Cancer Centre Singapore Singapore 169610 Singapore
- Kar Perng Low
- Division of Radiation Oncology and Division of Medical Sciences National Cancer Centre Singapore Singapore 169610 Singapore
- Gek San Tan
- Translational Pathology Centre Department of Molecular Pathology Singapore General Hospital Singapore 169856 Singapore
- Tony K. H. Lim
- Department of Anatomical Pathology Singapore General Hospital Singapore 169856 Singapore
- Jacqueline S. G. Hwang
- Department of Anatomical Pathology Singapore General Hospital Singapore 169856 Singapore
- Bo Li
- Department of Biochemistry and Molecular Biology Zhongshan School of Medicine Sun Yat‐sen University Guangzhou 510080 P. R. China
- Qi‐Sheng Feng
- Sun Yat‐sen University Cancer Center State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy Guangzhou 510060 P. R. China
- Xiaojun Xia
- Sun Yat‐sen University Cancer Center State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy Guangzhou 510060 P. R. China
- Yun‐Fei Xia
- Sun Yat‐sen University Cancer Center State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy Guangzhou 510060 P. R. China
- Josephine Ko
- Department of Clinical Oncology University of Hong Kong Pok Fu Lam Hong Kong SAR P. R. China
- Wei Dai
- Department of Clinical Oncology University of Hong Kong Pok Fu Lam Hong Kong SAR P. R. China
- Maria L. Lung
- Department of Clinical Oncology University of Hong Kong Pok Fu Lam Hong Kong SAR P. R. China
- Anthony T. C. Chan
- Department of Clinical Oncology State Key Laboratory of Translational Oncology Prince of Wales Hospital The Chinese University of Hong Kong Shatin, New Territories Hong Kong SAR P. R. China
- Dennis Y. M. Lo
- Department of Chemical Pathology Li Ka Shing Institute of Health Sciences State Key Laboratory of Translational Oncology The Chinese University of Hong Kong Shatin, New Territories Hong Kong SAR P. R. China
- Mu‐Sheng Zeng
- Sun Yat‐sen University Cancer Center State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy Guangzhou 510060 P. R. China
- Hai‐Qiang Mai
- Sun Yat‐sen University Cancer Center State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy Guangzhou 510060 P. R. China
- Jianjun Liu
- Guangdong Provincial People's Hospital Guangdong Academy of Medical Sciences Guangzhou 510080 P. R. China
- Yi‐Xin Zeng
- Sun Yat‐sen University Cancer Center State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy Guangzhou 510060 P. R. China
- Jin‐Xin Bei
- Sun Yat‐sen University Cancer Center State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy Guangzhou 510060 P. R. China
- DOI
- https://doi.org/10.1002/advs.201903727
- Journal volume & issue
-
Vol. 7,
no. 10
pp. n/a – n/a
Abstract
Abstract Germline polymorphisms are linked with differential survival outcomes in cancers but are not well studied in nasopharyngeal carcinoma (NPC). Here, a two‐phase association study is conducted to discover germline polymorphisms that are associated with the prognosis of NPC. The discovery phase includes two consecutive hospital cohorts of patients with NPC from Southern China. Exome‐wide genotypes at 246 173 single nucleotide polymorphisms (SNPs) are determined, followed by survival analysis for each SNP under Cox proportional hazard regression model. Candidate SNP is replicated in another two independent cohorts from Southern China and Singapore. Meta‐analysis of all samples (n = 5553) confirms that the presence of rs1131636‐T, located in the 3′‐UTR of RPA1, confers an inferior overall survival (HR = 1.33, 95% CI = 1.20–1.47, P = 6.31 × 10−8). Bioinformatics and biological assays show that rs1131636 has regulatory effects on upstream RPA1. Functional studies further demonstrate that RPA1 promotes the growth, invasion, migration, and radioresistance of NPC cells. Additionally, miR‐1253 is identified as a suppressor for RPA1 expression, likely through regulation of its binding affinity to rs1131636 locus. Collectively, these findings provide a promising biomarker aiding in stratifying patients with poor survival, as well as a potential drug target for NPC.
Keywords
- biomarkers
- cancer prognosis
- germline polymorphisms
- nasopharyngeal carcinoma
- RPA1
- single nucleotide polymorphisms
